| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Metocurine Iodide |
| Active Ingredient | Metocurine iodide |
| US Brand Names | Metubine Iodide |
| Drug Category | General Medicine |
| Drug Class | Adjunct therapy, Palliative treatment, Immunosuppressive therapy, Targeted therapy |
| Route of Administration | Intravenous |
| FDA Approval Status | FDA Approved (December 1948); Withdrawn (August 1998) Approved |
Metocurine Iodide: Overview
Metocurine Iodide is a semisynthetic benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent derived from tubocurarine. It was historically used as an adjunct to general anesthesia to induce skeletal muscle relaxation during surgery and mechanical ventilation.
What Is Metocurine Iodide & How Does It Work?
Metocurine Iodide operates as a competitive antagonist at nicotinic acetylcholine receptors located on the post-synaptic motor endplate of skeletal muscle fibers. At the cellular level, it competes directly with endogenous acetylcholine for binding sites on the neuronal acetylcholine receptor subunit alpha-2. By blocking acetylcholine from binding, Metocurine Iodide prevents membrane depolarization, halting muscle impulse conduction and inducing flaccid muscle paralysis. This neuromuscular blockade is reversible using acetylcholinesterase inhibitors such as neostigmine, edrophonium, or pyridostigmine, which increase acetylcholine concentration at the neuromuscular junction to outcompete the drug.
Is Metocurine Iodide FDA Approved?
Metocurine Iodide received official prescription approval from the United States Food and Drug Administration in December 1948 under the brand name Metubine Iodide. The drug was later discontinued and voluntarily withdrawn from the US market in August 1998 as newer nondepolarizing neuromuscular blockers with superior safety profiles became available. In historical General Medicine and surgical settings, anesthesiologists utilized Metocurine Iodide to facilitate endotracheal intubation and control muscle contractions.
What Is Metocurine Iodide Used For?
- Historical use as an adjunct to general anesthesia to induce skeletal muscle relaxation during surgical procedures.
- Facilitation of endotracheal intubation and management of mechanical ventilation in critical care.
- Historical reduction of the intensity of skeletal muscle contractions during electroconvulsive therapy (ECT).
Before Taking Metocurine Iodide: Contraindications & Precautions
Because Metocurine Iodide induces complete respiratory muscle paralysis and possesses histamine-releasing capabilities, strict clinical precautions were required prior to administration.
Who Should Not Take Metocurine Iodide?
Metocurine Iodide is strictly contraindicated in patients with known hypersensitivity to metocurine, tubocurarine, or iodide compounds. It must not be administered to patients without established artificial airway control and full mechanical ventilatory support. Patients with severe asthma or a history of severe allergic reactions should avoid Metocurine Iodide due to its moderate risk of inducing systemic histamine release.
Metocurine Iodide: Pregnancy & Fertility
Clinical safety data regarding Metocurine Iodide during pregnancy demonstrate that small amounts cross the placental barrier, though standard surgical doses were historically used during cesarean sections without direct fetal harm. It should be administered during pregnancy only when clearly needed and under direct anesthesia supervision. Studies assessing the direct impact of Metocurine Iodide on human fertility demonstrate no conclusive evidence of reproductive toxicity.
Tell Your Doctor Before Taking Metocurine Iodide
Inform your anesthesiologist if you have a history of myasthenia gravis, myasthenic syndrome, or other neuromuscular diseases. Disclose any existing kidney dysfunction, liver disease, or cardiac arrhythmias before undergoing anesthesia. List all prescription medications, aminoglycoside antibiotics, and anesthetics currently being administered.
Metocurine Iodide: Dosage & Administration
Metocurine Iodide was formulated as a sterile 2 mg/mL liquid solution intended exclusively for intravenous injection by trained anesthesia professionals.
- Intravenous Solution (2 mg/mL): Administered as a slow intravenous bolus injection.
- Neuromuscular Monitoring: Administered most advantageously when monitored using peripheral nerve stimulation to assess muscle twitch response.
- Reversal Protocols: Reversed at the end of surgery using intravenous anticholinesterase agents paired with anticholinergic drugs.
Standard Metocurine Iodide Dosing
In historical adult surgical practice, the average initial dose of Metocurine Iodide for muscle relaxation ranged from 0.2 mg/kg to 0.4 mg/kg administered intravenously over 30 to 60 seconds. Maintenance doses of 0.5 mg to 1 mg were administered as needed based on peripheral nerve stimulation monitoring. Doses were reduced significantly when co-administered with potent inhalational anesthetics like isoflurane or enflurane.
How Metocurine Iodide Is Administered
Metocurine Iodide was injected directly into a secure intravenous line by an anesthesiologist. Continuous monitoring of muscle twitch response using a peripheral nerve stimulator was recommended to tailor dosing and prevent prolonged paralysis.
Metocurine Iodide: Clinical Efficacy & Research
Established clinical consensus confirmed that Metocurine Iodide provided reliable, intermediate-to-long-acting neuromuscular blockade for major surgical procedures. Clinical trials demonstrated that Metocurine Iodide produced twice the neuromuscular blocking potency of tubocurarine with a lower incidence of severe hypotension and autonomic ganglion blockade. However, research also highlighted its moderate propensity for triggering histamine release and variable clearance in patients with renal impairment, leading to its replacement by modern aminosteroid and benzylisoquinolinium agents like vecuronium and cisatracurium.
Metocurine Iodide: Side Effects & Safety Profile
This medication does not have an FDA Black Box Warning. Although Metocurine Iodide lacked a formal boxed warning prior to its withdrawal, official prescribing guidelines emphasized that the drug should be administered only by clinicians trained in airway management and mechanical ventilation.
Metocurine Iodide carries predictable adverse effect risks linked to neuromuscular blockade, autonomic ganglion inhibition, and systemic histamine release.
Common Metocurine Iodide Side Effects
- Transient skin flushing, erythema, or localized hives due to histamine release
- Mild hypotension or transient blood pressure drops
- Mild sinus tachycardia or minor heart rate fluctuations
- Excessive bronchial secretions or mild salivation
Serious Metocurine Iodide Adverse Events
- Prolonged respiratory paralysis and post-operative apnea requiring extended mechanical ventilation
- Severe bronchospasm or anaphylactoid reactions driven by acute histamine release
- Profound hypotension and circulatory collapse secondary to autonomic ganglion blockade
- Severe muscle weakness in patients with underlying myasthenia gravis or electrolyte imbalances
Managing Metocurine Iodide Side Effects
If prolonged neuromuscular blockade occurs, mechanical ventilation must be maintained while administering neostigmine combined with atropine or glycopyrrolate. If severe hypotension or bronchospasm develops, intravenous fluids, vasopressors, and antihistamines should be administered immediately.
Metocurine Iodide: Interactions & What to Avoid
Combining Metocurine Iodide with medications that impair neuromuscular transmission markedly enhances muscle paralysis.
Metocurine Iodide: Interactions
- Inhalational anesthetics (isoflurane, enflurane, halothane): Significantly potentiate the intensity and duration of Metocurine Iodide neuromuscular blockade.
- Aminoglycoside antibiotics (gentamicin, tobramycin, neomycin): Enhance neuromuscular inhibition, increasing the risk of prolonged respiratory depression.
- Electrolyte imbalances (hypokalemia, hypocalcemia, hypermagnesemia): Potentiate non-depolarizing muscle relaxation and impair spontaneous recovery.
Metocurine Iodide: Food & Alcohol
Dietary intake does not interfere with intravenous Metocurine Iodide, though standard pre-surgical fasting protocols must be strictly followed under general anesthesia. Alcohol consumption enhances central nervous system depression and can alter cardiovascular stability during anesthesia.
Metocurine Iodide: Missed Dose, Overdose & Storage
Because Metocurine Iodide was administered exclusively during controlled surgical procedures, routine patient self-administration guidelines do not apply.
Missed Dose of Metocurine Iodide
Missed dose scenarios do not occur, as Metocurine Iodide was administered on-demand as a single procedure-specific injection by healthcare providers.
Metocurine Iodide: Overdose & Emergency
Metocurine Iodide overdose results in prolonged muscle paralysis, total apnea, and severe hypotension. Emergency management requires continuous mechanical ventilation, airway maintenance, and administration of reversal agents like neostigmine paired with atropine once partial spontaneous recovery begins.
How To Store Metocurine Iodide
Store Metocurine Iodide injection vials at controlled room temperature between 15°C and 30°C (59°F and 86°F). Keep containers protected from light, freezing, and heat, and restrict access to authorized medical personnel.
Metocurine Iodide: Patient Management & Monitoring
Continuous electrophysiological and vital sign monitoring was mandatory whenever Metocurine Iodide was administered.
Tests Before Starting Metocurine Iodide
- Baseline evaluation of renal function and liver function to assess drug elimination pathways.
- Pre-anesthetic screening for underlying myopathies, myasthenia gravis, or history of severe allergies.
Monitoring During Metocurine Iodide Treatment
- Continuous peripheral nerve stimulation monitoring to evaluate twitch suppression and depth of neuromuscular blockade.
- Continuous monitoring of blood pressure, heart rate, electrocardiogram (ECG), and mechanical ventilatory parameters.
Metocurine Iodide: Do’s and Don’ts
- Do ensure complete mechanical ventilation support is operational before administering Metocurine Iodide.
- Do utilize a peripheral nerve stimulator to accurately titrate dosing and guide pharmacological reversal.
- Don’t administer Metocurine Iodide without an established endotracheal airway in place.
- Don’t attempt rapid reversal until initial spontaneous twitch recovery is demonstrated.
Frequently Asked Questions
What was Metocurine Iodide used for in surgery?
Metocurine Iodide was used as an anesthesia adjunct to relax skeletal muscles, facilitate breathing tube insertion, and manage mechanical ventilation.
Is Metocurine Iodide approved by the FDA?
Metocurine Iodide was approved by the US FDA in December 1948 under the brand name Metubine Iodide, but was voluntarily withdrawn in August 1998.
How does Metocurine Iodide cause muscle paralysis?
Metocurine Iodide competitively blocks acetylcholine from binding to nicotinic receptors at the neuromuscular junction, preventing muscle contraction signals.
How is Metocurine Iodide paralysis reversed?
Neuromuscular blockage from Metocurine Iodide is reversed using acetylcholinesterase inhibitors like neostigmine paired with an anticholinergic like atropine.
Can Metocurine Iodide cause low blood pressure?
Metocurine Iodide can cause blood pressure drops due to its moderate release of systemic histamine and mild autonomic ganglion blocking activity.
How was Metocurine Iodide monitored during surgery?
Anesthesiologists monitored Metocurine Iodide using a peripheral nerve stimulator to check muscle twitch responses and gauge paralysis depth.
Why was Metocurine Iodide replaced by newer muscle relaxants?
It was replaced because newer nondepolarizing blockers offer cleaner safety profiles, faster recovery, and lower risks of histamine release.
References
- United States Food and Drug Administration. Metubine Iodide (Metocurine Iodide) Historical Prescribing and Approval Documentation.
- DrugBank Online Database. Metocurine Iodide Compound Summary (Accession Number DB00416).
- National Center for Biotechnology Information. PubChem Compound Summary for Metocurine Iodide.
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.
